How can we find that sweet spot between patient-centricity and profitability - the modern pharma company is constantly faced with this dilemma? While patient-centricity first took root in the R&D side of the business. Its tendrils have now extended outwards, touching and engaging with every function…and commercial is no exception.
Yet we can’t help but ask ourselves, how patient-centric is commercial pharma?
In eyeforpharma’s latest white paper “Patient Centricity Works: Ensuring a patient-first strategy drives real results in commercial pharma”, we delve into how you can find that ‘sweet spot’ between patient-centricity and profitability. We worked with several pharma companies to bring you real examples of how this can work in your organisation including:
- UCB: On how you can make it personal
- Formalizing patient-centricity across Sunovion
- The patient as at priority at Takeda
- Astellas strives to understand the patient experience
- Defining patient-centricity at AstraZeneca
- The patient is front and centre at Roche Diabetes Care
- Nestlé seeks to understand a new generation of ‘patients’
Enjoy,
Cintia
Cintia Hernández I Head of Latin America I eyeforpharma
E – chernandez@eyeforpharma.com I T - +44 207 375 7592 I 7-9 Fashion Street, London. E16PX
style="display:block" data-ad-format="autorelaxed" data-ad-client="ca-pub-6652631670584205" data-ad-slot="7514086806">
Comentários